Login to Your Account

Financings Roundup

Thursday, August 30, 2012
• Coronado Biosciences Inc., of Burlington, Mass., closed a $15 million secured loan facility with Hercules Technology Growth Capital Inc. Proceeds will support Coronado's clinical programs for Trichuris suis ova (CNDO-201), a biologic therapy for autoimmune disease, and CNDO-109, a biologic therapy for acute myeloid leukemia and solid tumors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription